Clinical Cancer Research · 2024 · 16 citations · 29 references
Our data support an initial strategy of extensive resection in patients with oligodendroglioma and astrocytoma. Other important prognostic factors differ between these tumor types, urging researchers and clinicians to keep treating these tumors as separate entities.
29
Mechanisms and therapeutic implications of hypermutation in gliomas
Mehdi Touat, Yvonne Y. Li, Adam N. Boynton et al. · Nature · 2020 · 661 citations · Full text
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal et al. · New England Journal of Medicine · 2023 · 606 citations · Full text
Philipp Kickingereder, Fabian Isensee, Irada Tursunova et al. · The Lancet Oncology · 2019 · 420 citations · Full text